ALKERMES reported $1.04B in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Amgen AMGN:US USD 3.65B 1.23B
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Coherus Biosciences CHRS:US USD -97133000 74.5M
Eli Lilly And LLY:US USD 10.07B 1.53B
Gilead Sciences GILD:US USD 21.06B 821M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Intra Cellular Therapies ITCI:US USD 685.42M 36.78M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
JAZZ PHA JAZZ:US USD 2.75B 455.59M
Marinus Pharmaceuticals MRNS:US USD 82M 77.2M
Minerva Neurosciences NERV:US USD -14246000 5.86M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Otsuka Holdings 4578:JP JPY 2.3T 71.7B
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Revance Therapeutics RVNC:US USD 145.71M 148.34M
Teva Pharmaceutical Industries TEVA:US USD 8.77B 269M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B